BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 13, 2003
View Archived Issues
As Expected, VaxGen's Second AidsVax Phase III In HIV Misses
VaxGen Inc.'s investigational vaccine for the prevention of HIV infection failed to hit primary or secondary endpoints in a Phase III trial conducted in Thailand. (BioWorld Today)
Read More
YM Licenses European Rights To Cancer Drug In $30M Deal
Read More
In Seawater, Vibrio cholerae Form Calcium-Dependent Biofilms In Order To Survive
Read More
With Phase III Ongoing, Repligen Presents Preclinical Secretin Data
Read More
Other News To Note
Read More